Ishii T, Hirose H, Kawai T, Hayashi K, Maruyama H, Saito I, Saruta T
Department of Internal Medicine and Health Center, Keio University School of Medicine, Tokyo, Japan.
Metabolism. 2001 Nov;50(11):1301-7. doi: 10.1053/meta.2001.27228.
The present study was performed to investigate the effects of the intestinal fatty acid-binding protein (FABP2) gene Ala54Thr polymorphism and the beta(3)-adrenergic receptor (beta3AR) gene Trp64Arg polymorphism on body mass index (BMI), blood pressure, heart rate, glucose and lipid profiles, and serum leptin level in 196 young men aged 21 to 39 years, 186 older normoglycemic men (fasting plasma glucose [FPG] < 110 mg/dL) aged 40 to 65 years, and 122 older hyperglycemic men, including 77 type 2 diabetic patients. Genomic DNA was extracted from the peripheral blood, and these polymorphisms were assessed by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. In the older groups, the beta3AR Arg64-allele frequency tended to be lower and the FABP2 Thr/Thr54 genotype frequency tended to be higher in hyperglycemic patients, although these differences did not reach statistical significance. Also, there were no significant differences in the genotype or allele frequency of either variant between the 27 hyperlipidemic and 204 normolipidemic subjects. In the younger group, there were no significant differences in any of the parameters measured between the genotypes of beta3AR or FABP2. In the older normoglycemic subjects, heart rate was significantly lower (P =.037) in beta3AR Arg64-positive subjects, and FPG was significantly higher in subjects with the FABP2 Thr/Thr genotype than the other genotypes (99.8 +/- 5.6 v 96.5 +/- 5.6 mg/dL, P =.010). In the older hyperglycemic group, the beta3AR Arg64-positive group had significantly lower high-density lipoprotein (HDL) cholesterol and free fatty acid (FFA) levels (P =.024 and P =.043, respectively). There were no synergistic effects of these 2 variants on any measured parameter, but only the FABP2 Thr/Thr genotype was related to a higher FPG in the older normoglycemic men. In conclusion, no major difference was associated with the beta3AR Trp64Arg or FABP2 Ala54Thr polymorphism in terms of type 2 diabetes or hyperlipidemia in young to older Japanese men. However, a slight but significant increase in FPG was observed in older Japanese men with the FABP2 Thr/Thr genotype.
本研究旨在调查肠道脂肪酸结合蛋白(FABP2)基因Ala54Thr多态性和β3 - 肾上腺素能受体(β3AR)基因Trp64Arg多态性对196名年龄在21至39岁的年轻男性、186名年龄在40至65岁的血糖正常的老年男性(空腹血糖[FPG]<110mg/dL)以及122名老年高血糖男性(包括77名2型糖尿病患者)的体重指数(BMI)、血压、心率、血糖和血脂谱以及血清瘦素水平的影响。从外周血中提取基因组DNA,并通过聚合酶链反应(PCR)-限制性片段长度多态性(RFLP)方法评估这些多态性。在老年组中,高血糖患者的β3AR Arg64等位基因频率趋于降低,FABP2 Thr/Thr54基因型频率趋于升高,尽管这些差异未达到统计学意义。此外,27名高脂血症患者和204名血脂正常的受试者之间,这两种变体的基因型或等位基因频率均无显著差异。在年轻组中,β3AR或FABP2基因型之间所测量的任何参数均无显著差异。在血糖正常的老年受试者中,β3AR Arg64阳性受试者的心率显著较低(P = 0.037),FABP2 Thr/Thr基因型受试者的FPG显著高于其他基因型受试者(99.8±5.6对96.5±5.6mg/dL,P = 0.010)。在老年高血糖组中,β3AR Arg64阳性组的高密度脂蛋白(HDL)胆固醇和游离脂肪酸(FFA)水平显著较低(分别为P = 0.024和P = 0.043)。这两种变体对任何测量参数均无协同作用,但仅FABP2 Thr/Thr基因型与血糖正常的老年男性较高的FPG相关。总之,在日本年轻至老年男性中,β3AR Trp64Arg或FABP2 Ala54Thr多态性与2型糖尿病或高脂血症无关。然而,观察到FABP2 Thr/Thr基因型的日本老年男性FPG略有但显著升高。